465 related articles for article (PubMed ID: 795579)
1. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
[TBL] [Abstract][Full Text] [Related]
2. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
Moutsopoulos HM; Fauci AS
J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
[TBL] [Abstract][Full Text] [Related]
4. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M
Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.
Feldmann JL; Becker MJ; Moutsopoulos H; Fye K; Blackman M; Epstein WV; Talal N
J Clin Invest; 1976 Jul; 58(1):173-9. PubMed ID: 6490
[TBL] [Abstract][Full Text] [Related]
8. Immune function in patients with multiple myeloma (delayed cutaneous reactivity and lymphocytes bearing receptors for sheep, human and mouse erythrocytes).
Dammacco F; Miglietta A; Bonomo L
Ric Clin Lab; 1977; 7(4):343-53. PubMed ID: 307801
[TBL] [Abstract][Full Text] [Related]
9. Characterization of thymosin-responsive peripheral blood null cells.
Kaplan J
Cancer Treat Rep; 1978 Nov; 62(11):1757-61. PubMed ID: 310342
[TBL] [Abstract][Full Text] [Related]
10. Thymosin-inducible lymphocytes in the peripheral blood of patients with malignant melanoma.
Byrom NA; Campbell MA; Dean AJ; Timlin DM; Volkers C; Bodenham DC; Hobbs JR
Cancer Treat Rep; 1978 Nov; 62(11):1769-74. PubMed ID: 310343
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.
Starkebaum G; Arend WP
J Clin Invest; 1979 Oct; 64(4):902-12. PubMed ID: 479375
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases.
Markeljević J; Batinić D; Uzarević B; Bozikov J; Cikes N; Babić-Naglić D; Horvat Z; Marusić M
J Rheumatol; 1994 Dec; 21(12):2225-30. PubMed ID: 7535356
[TBL] [Abstract][Full Text] [Related]
13. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
14. Thymosin administration in autoimmune disorders.
Lavastida MT; Goldstein AL; Daniels JC
Thymus; 1981 Feb; 2(4-5):287-95. PubMed ID: 6972106
[TBL] [Abstract][Full Text] [Related]
15. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
Rauch J; Massicotte H; Tannenbaum H
J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652
[TBL] [Abstract][Full Text] [Related]
16. Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.
Glinski W; Gershwin ME; Steinberg AD
J Clin Invest; 1976 Mar; 57(3):604-14. PubMed ID: 55418
[TBL] [Abstract][Full Text] [Related]
17. Profiles of antibodies to histones, DNA and IgG in patients with systemic rheumatic diseases determined by ELISA.
Gripenberg M; Helve T; Kurki P
J Rheumatol; 1985 Oct; 12(5):934-9. PubMed ID: 3878880
[TBL] [Abstract][Full Text] [Related]
18. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
20. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
